AI Used In Drug R&D Likely Exempt From Tough EU AI Rules, Says EFPIA

The European Commission’s landmark AI Act will introduce strict new rules for AI systems, with the exception of products used solely for scientific research, something that could be good news for pharma, according to industry body EFPIA.